Age-related inflammatory mediators in coronary artery disease (II).
Age-related inflammatory mediators in coronary artery disease (II).
复制标题
冠状动脉疾病中与年龄相关的炎症介质(II)。
DOI:
10.1016/j.ijcard.2013.07.157
复制
发表时间:
2013-10
期刊:
影响因子:
--
通讯作者:
Bao,S
中科院分区:
文献类型:
--
作者:
Duflou,J;Zhang,X;Puranik,S;Bao,S
Coronary artery disease (CAD), a major cause of morbidity and mortality globally, is among the most common causes of sudden natural deaths in Australians under the age of 35 years [1]. Although inflammation is a key process in atherogenesis, little is known about specific regulators of inflammation in premature onset CAD. Inflammation contributes to the development of CAD, and cytokines are specifically implicated in the pathogenesis of premature CAD [2]. Knowledge regarding novel interleukins, eg IL-27,-29 and IL-31–34, has emerged as they relate to various inflammatory disease states (eg, colitis, psoriasis, and COPD), but little is known regarding their specific role in atherogenesis.Coronary artery specimens were obtained from 50 premature (≤ 60 y) and 50 mature (N60 y) male decedents where CAD was the cause of death at post-mortems performed at the NSW Department of Forensic Medicine, Australia, between 2009 and 2012, as described previously [2]. These cases had no recorded history of illicit drug use. Twenty non-cardiac-death controls were further recruited. This study was conducted in strict compliance with the Sydney Local Health District Ethics Review Committee, Australia. Coronary artery sections of culprit atheromatous plaque from premature and mature CAD cases and controls were stained with H&E and Movat's, as described [3]. The sections were further stained for IL-27,-29, and-31–34. Each of the polyclonal rabbit anti-human primary antibodies (Abcam, Sydney, Australia) were followed by polymer HRP goat anti-rabbit immunoglobulin (Dako, Sydney, Australia). The positive staining was photographed and quantified using Image-Pro® Plus 7, as described [2]. Statistical analysis was performed by parametric one-way ANOVAs and Tukey post-hoc tests. The levels of statistical significance was defined as pb 0.05 for significant results.
登录
查看更多内容
影响因子:
27.4
作者:
Dinarello, C. A.;Kim, S-H
通讯作者:
Kim, S-H
影响因子:
14.2
作者:
Neis, Mark M.;Peters, Bettina;Hermanns, Heike M.
通讯作者:
Hermanns, Heike M.
DOI:
10.1084/jem.20071868
发表时间:
2008-02-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Miller AM;Xu D;Asquith DL;Denby L;Li Y;Sattar N;Baker AH;McInnes IB;Liew FY
通讯作者:
Liew FY
影响因子:
6.5
作者:
Shibata, Sayaka;Tada, Yayoi;Sato, Shinichi
通讯作者:
Sato, Shinichi
DOI:
10.1097/pas.0b013e31824aae0a
发表时间:
2012-01
期刊:
Medicine, Science and the Law
影响因子:
--
作者:
R. Puranik;C. Chow;Johan Duflou;M. Kilborn;M. McGuire
通讯作者:
R. Puranik;C. Chow;Johan Duflou;M. Kilborn;M. McGuire